TheraRadar

Infectious Disease Drugs

1,157 FDA-approved drugs

Recent Approvals

IDVYNSO
DORAVIRINE
IDVYNSO™ is indicated as a complete two-drug regimen for the treatment of human immunodeficiency vir...
2026-04-20
Merck
RIFAXIMIN
RIFAXIMIN
2026-03-19
ZYDUS PHARMS USA INC
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE
EMTRICITABINE
BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1...
2026-01-30
Apotex
RILPIVIRINE
RILPIVIRINE
2026-01-29
STRIDES ARCOLAB LTD
RILPIVIRINE HYDROCHLORIDE
RILPIVIRINE HYDROCHLORIDE
human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-naïve patients 2 y...
2026-01-29
SOMERSET THERAPS LLC
NUZOLVENCE
ZOLIFLODACIN
uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients 12 ...
2025-12-12
ENTASIS THERAP
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE
CIPROFLOXACIN HYDROCHLORIDE
acute otitis externa in adult and pediatric patients, one year and older, due to susceptible strains...
2025-11-10
COSETTE PHARMS NC
DALBAVANCIN HYDROCHLORIDE
DALBAVANCIN HYDROCHLORIDE
adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused...
2025-10-23
Fresenius Kabi
CONTEPO
FOSFOMYCIN DISODIUM
patients 18 years of age and older with complicated urinary tract infections (cUTI) including acute ...
2025-10-22
MEITHEAL
CLOTIC
CLOTRIMAZOLE
Uses Cures athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis)...
2025-09-26
CARWIN PHARM ASSOC
YEZTUGO
LENACAPAVIR
pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolesce...
2025-06-18
Gilead Sciences
ENFLONSIA
CLESROVIMAB-CFOR
the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and ...
2025-06-09
Merck
EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE
EMTRICITABINE
use as a complete regimen for the treatment of HIV-1 infection in patients weighing at least 35 kg (...
2025-05-20
Viatris
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
PIPERACILLIN SODIUM
the treatment of: Intra-abdominal infections in adult and pediatric patients 2 months of age and old...
2025-04-03
B BRAUN MEDICAL
BLUJEPA
GEPOTIDACIN MESYLATE
the following infections caused by susceptible microorganisms: • Uncomplicated urinary tract infecti...
2025-03-25
GSK
EMBLAVEO
AVIBACTAM SODIUM
EMBLAVEO is a combination of aztreonam, a monobactam antibacterial, and avibactam, a beta-lactamase ...
2025-02-07
AbbVie
RALTEGRAVIR POTASSIUM
RALTEGRAVIR POTASSIUM
2024-12-19
HETERO LABS LTD III
ORLYNVAH
PROBENECID
uncomplicated urinary tract infections (uUTI) caused by the designated microorganisms Escherichia co...
2024-10-25
ITERUM THERAP
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ
2024-09-05
MATRIX LABS LTD
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
EMTRICITABINE
2024-05-17
Lupin
Showing 20 of 1157 drugs

Drug Classes

Azole Antifungal 17
Nitroimidazole Antimicrobial 12
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor 10
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor 10
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor 8
Cytochrome P450 3A Inhibitor 7
Corticosteroid 5
Nitrofuran Antibacterial 5
Rifamycin Antimycobacterial 4
Anthelmintic 4

Quick Stats

Total Drugs
1157
Companies
333
Drug Classes
60
Latest Approval
2026-04-20